Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

January 25, 2023

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Triple Negative Breast Cancer
Interventions
RADIATION

Genomically Guided Radiation Therapy

Participants will receive treatment 5 days per week, in once daily fractions. The total dose will be 50 Gy in 25 fractions or 42.56 Gy in 16 fractions with or without a boost of 10 Gy in 5 fractions to the cavity.

RADIATION

Genomically Guided Radiation Therapy

Participants will receive treatment 5 days per week, in once daily fractions. The total dose will be 50 Gy in 25 fractions or 42.56 Gy in 16 fractions with a boost of 10 Gy in 5 fractions to the cavity.

Trial Locations (2)

33612

RECRUITING

Moffitt Cancer Center, Tampa

33756

RECRUITING

Morton Plant Hospital - Baycare Health System, Clearwater

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER